Displaying 385 - 396 of 452
Metabolism, Alcohol & Toxicity
5

Novo Nordisk:  NASH – the metabolic disease of the liver - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
5

Novo Nordisk:  NASH – the metabolic disease of the liver - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
5

Novo Nordisk:  NASH – the metabolic disease of the liver - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
5

Novo Nordisk:  NASH – the metabolic disease of the liver - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
5

Novo Nordisk:  NASH – the metabolic disease of the liver - Digital ILC 2020

View
Liver Tumours
6

Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021

View
Liver Tumours
6

Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021

View
Liver Tumours
6

Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021

View
Liver Tumours
6

Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021

View
Liver Tumours
6

Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021

View
Liver Tumours
6

Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Bristol-Myers Squibb: Evolving Treatment Landscape of HCC - Digital ILC 2020

View
Displaying 385 - 396 of 452